Li, C., Feng, Y., & Shao, W. (2020). Changes of serum miR-223-3p in patients with oral cancer treated with TPF regimen and the prognosis. Oncology letters, 19(3), 2527-2532. https://doi.org/10.3892/ol.2020.11258
Chicago Style (17th ed.) CitationLi, Chunru, Yao Feng, and Weiran Shao. "Changes of Serum MiR-223-3p in Patients with Oral Cancer Treated with TPF Regimen and the Prognosis." Oncology Letters 19, no. 3 (2020): 2527-2532. https://doi.org/10.3892/ol.2020.11258.
MLA (9th ed.) CitationLi, Chunru, et al. "Changes of Serum MiR-223-3p in Patients with Oral Cancer Treated with TPF Regimen and the Prognosis." Oncology Letters, vol. 19, no. 3, 2020, pp. 2527-2532, https://doi.org/10.3892/ol.2020.11258.
Warning: These citations may not always be 100% accurate.